首页> 外文OA文献 >318. Development of Optimized AAV Serotype Vectors for the Potential Gene Therapy of Cystic Fibrosis

【2h】

318. Development of Optimized AAV Serotype Vectors for the Potential Gene Therapy of Cystic Fibrosis

机译：318.开发用于囊性纤维化潜在基因治疗的最佳AAV血清型载体

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
引文网络
相似文献
相关主题

摘要

2017-08-30T02:06:24Z

机译：2017-08-30T02：06：24Z

著录项

作者
Division of Pulmonary and Allergy, Department of Pediartics, University of Florida, Gainesville, FL ( host institution ); Colon-Cortes, Yanerys ( UF author ); Sharma, Prativa ( UF author ); Ling, Chen ( UF author ); Abu-Hasan, Mutasim ( UF author ); Srivastava, Arun ( UF author ); Aslanidi, George ( UF author );
展开▼
作者单位

展开▼
年度 2015
总页数
原文格式 PDF
正文语种 English
中图分类

相似文献

外文文献
中文文献
专利

1. Adeno-Associated Virus (AAV) gene therapy for cystic fibrosis: current barriers and recent developments [J] . Guggino William B., Cebotaru Liudmila Expert opinion on biological therapy . 2017,第7a12期

机译：腺相关病毒（AAV）基因治疗囊性纤维化：当前障碍和最近的发展
2. Development of Optimized AAV Serotype Vectors for High-Efficiency Transduction at Further Reduced Doses [J] . Ling Chen, Li Baozheng, Ma Wenqin, Human gene therapy methods. . 2016,第4期

机译：进一步减少剂量的高效转导的优化AAV血清型载体的开发
3. Development of optimized AAV3 serotype vectors: Mechanism of high-efficiency transduction of human liver cancer cells [J] . ChengB., LingC., DaiY., Gene therapy . 2012,第4期

机译：优化的AAV3血清型载体的开发：人肝癌细胞高效转导的机制
4. Cystic fibrosis transmembrane conductance regulator gene mutations cause 'black' pigment gallstone formation: new insights from mouse models and implications for therapeutic interventions in cystic fibrosis [C] . A. L. BRODERICK, H. WITTENBURG, M. A. LYONS, Falk Symposium . 2004

机译：囊性纤维化跨膜电导调节剂基因突变引起'黑色'颜料胆结石形成：来自小鼠模型的新见解，以及对囊性纤维化治疗干预的影响
5. Investigation and application of novel adeno-associated viral vectors for Cystic Fibrosis gene therapy. [D] . Steines, Benjamin Richard. 2015

机译：新型腺相关病毒载体用于囊性纤维化基因治疗的研究与应用。
6. Prevalence of Neutralizing Antibodies against Adeno-Associated Virus (AAV)Types 2 5 and 6 in Cystic Fibrosis and Normal Populations: Implications for Gene Therapyusing AAV Vectors [O] . Christine L. Halbert, A. Dusty Miller, Sharon McNamara, -1

机译：腺相关病毒（AAV）中和抗体的流行率。囊性纤维化和正常人群中的2型5型和6型：基因治疗的意义使用AAV向量
7. Prevalence of Neutralizing Antibodies Against Adeno-Associated Virus (AAV) Types 2, 5, and 6 in Cystic Fibrosis and Normal Populations: Implications for Gene Therapy Using AAV Vectors [O] . Christine L. Halbert, A. Dusty Miller, Sharon Mcnamara, 2006

机译：患有腺相关病毒（AAV）类型2,5和6型中和抗体的患病率在囊性纤维化和正常群体中：使用AAV载体对基因治疗的影响

318. Development of Optimized AAV Serotype Vectors for the Potential Gene Therapy of Cystic Fibrosis

摘要

著录项

引文网络

相似文献

相关主题

期刊订阅